Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
Kenneth H MayerKelly E SeatonYunda HuangNicole A GrunenbergAbby IsaacsMary A AllenJulie E LedgerwoodIan FrankMagdalena E SobieszczykLindsey R BadenBenigno RodriguezHong Van TieuGeorgia D TomarasAaron DealDerrick GoodmanRobert T BailerGuido FerrariRyan JensenJohn HuralBarney S GrahamJohn R MascolaLawrence CoreyDavid C Montefiorinull nullnull nullPublished in: PLoS medicine (2017)
Clinical Trials Registration: NCT02165267.